Author

Dimitris C. Kanellis

Science for Life LaboratoryORCID 0000-0001-8690-2010Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

Jiří BártekiD· 2 shared Alba CormaniD· 1 shared André G. DeslauriersiD· 1 shared Ann-Charlotte BjörklundiD· 1 shared Eirini P. PapapetrouiD· 1 shared Elli PapaemmanuiliD· 1 shared Eva Hellström‐LindbergiD· 1 shared Gabriele TodiscoiD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jiří BártekORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyLeukemiaPeer-reviewedAug 26, 2025

SF3B1-mutant mis-splicing of UBA1 confers a targetable therapeutic vulnerability through UBA1 inhibition

Jonas Thier, Sophia Hofmann, Katharina Miria Kirchhof…·Vanessa Lundin

This study identifies UBA1 mis-splicing as a therapeutic target in SF3B1-mutant myelodysplastic syndromes, showing that UBA1 inhibition sensitizes these cells to treatment.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMay 11, 2020

A chemical screen identifies a link between lipid metabolism and mRNA translation

Alba Corman, Dimitris C. Kanellis, Maria Häggblad…·Óscar Fernández-Capetillo

This study identifies SPHK inhibitors as a new class of translation suppressors independent of mTOR, linking lipid metabolism to mRNA translation.

1 citation

humanexperimental assay

𝕏 PostBluesky